Citius Pharmaceuticals Ownership | Who Owns Citius Pharmaceuticals?


OverviewForecastFinancialsChart

Citius Pharmaceuticals Ownership Summary


Citius Pharmaceuticals is owned by 5.57% institutional investors, 3.09% insiders, and 91.34% retail investors. Vanguard group is the largest institutional shareholder, holding 1.51% of CTXR shares. Vanguard US Total Market Shares ETF is the top mutual fund, with 2.60% of its assets in Citius Pharmaceuticals shares.

CTXR Ownership Benchmark


TypeName% Inst% Insiders% Retail
StockCitius Pharmaceuticals5.57%3.09%91.34%
SectorHealthcare Stocks 42.54%10.83%46.63%
IndustryBiotech Stocks 45.22%10.75%44.04%

Institutional Shareholders


Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Vanguard group166.39K1.51%$206.32K
Blackrock1.81M1.14%$1.05M
Geode capital management119.77K1.09%$148.54K
Blackrock funding, inc. /de69.85K0.63%$86.61K
Northern trust27.02K0.25%$33.51K
Ubs group25.91K0.24%$32.13K
Newedge advisors25.40K0.23%$31.50K
State street23.27K0.21%$28.86K
Two sigma investments, lp21.80K0.20%$27.04K
Arkadios wealth advisors20.00K0.18%$24.80K

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Chelsea counsel4.63K0.00%$7.36K
Xtx topco15.92K0.00%$19.74K
Arkadios wealth advisors20.00K0.00%$24.80K
Legacy wealth managment, llc/id930.000.00%$1.15K
Luminist capital435.000.00%$596.00
Murphy & mullick capital management160.000.00%$251.00
Sbi securities4.02K0.00%$4.99K
Smallwood wealth investment management120.000.00%$148.00
Newedge advisors25.40K0.00%$31.50K
Legal & general group---

Top Buyers

HolderShares% AssetsChange
Bank of america corp /de/159.42K-107.23K
Vanguard group166.39K-86.29K
Geode capital management119.77K-43.68K
Citadel advisors24.70K-24.70K
Jane street group18.89K-18.89K

Top Sellers

HolderShares% AssetsChange
Armistice capital---7.28M
Blackrock1.81M--6.92M
Millennium management---1.16M
Nuveen asset management---484.65K
Y-intercept (hong kong)---389.47K

New Positions

HolderShares% AssetsChangeValue
Jane street group18.89K-18.89K$23.42M
Macquarie group6.89K-6.89K$4.02K
Russell investments group5.46K-5.46K$3.19K
Citigroup1.62K-1.62K$2.00K
Legacy wealth managment, llc/id930.000.00%930.00$1.15K

Sold Out

HolderChange
Eversource wealth advisors-16.00
Nelson, van denburg & campbell wealth management group-18.00
Larson financial group-45.00
Wr wealth planners-100.00
Pnc financial services group-177.00

Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Sep 30, 202535-612,699-34.03%57.82%1713.33%5-16.67%
Jun 30, 20253417.24%928,48646.11%828.06%1427.27%6-25.00%
Mar 31, 202529-12.12%635,4734.31%519.84%1157.14%8-65.22%
Dec 31, 20243-94.92%76,616-99.68%-0.02%--100.00%1-96.00%
Sep 30, 202455-21.43%23,175,356-23.61%133.66%12-62.50%2538.89%

Top Mutual Funds Shareholders


HolderShares% HoldingChange
Vanguard US Total Market Shares ETF4.14M2.60%-1.00
Vanguard Total Stock Mkt Idx Inv165.58K1.61%-
Vanguard Institutional Extnd Mkt Idx Tr69.99K0.48%-8.32K
Fidelity Extended Market Index50.83K0.30%4.50K
NT R2000 Index Fund - NL316.31K0.17%-58.09K
NT R2000 Value Index Fund - NL279.80K0.15%-55.32K
NT R2000 Index Fund - DC - NL - 2250.30K0.14%-47.02K
Northern Trust Russell 2000 Value Index249.69K0.14%6.16K
NT R2000 Value Index Fund - L249.69K0.14%6.16K
BlackRock Extended Equity Market K230.77K0.13%-98.00

Recent Insider Transactions


DateNameRoleActivityValue
Sep 27, 2019Mazur Leonard L Executive ChairmanBuy$1.72M
Sep 27, 2019Mazur Leonard L Executive ChairmanBuy$2.00M
Sep 27, 2019HOLUBIAK MYRON Z President and CEOBuy$500.00K
Sep 27, 2019HOLUBIAK MYRON Z President and CEOBuy$430.12K
Apr 03, 2019Mazur Leonard L Executive ChairmanBuy$1.80M

Insider Transactions Trends


DateBuySell
2024 Q3--
2024 Q2--
2024 Q1--
2023 Q4--
2023 Q1--

CTXR Ownership FAQ


Who Owns Citius Pharmaceuticals?

Citius Pharmaceuticals shareholders are primarily institutional investors at 5.57%, followed by 3.09% insiders and 91.34% retail investors. The average institutional ownership in Citius Pharmaceuticals's industry, Biotech Stocks , is 45.22%, which Citius Pharmaceuticals falls below.

Who owns the most shares of Citius Pharmaceuticals?

Citius Pharmaceuticals’s largest shareholders are Vanguard group (166.39K shares, 1.51%), Blackrock (1.81M shares, 1.14%), and Geode capital management (119.77K shares, 1.09%). Together, they hold 3.73% of Citius Pharmaceuticals’s total shares outstanding.

Does Blackrock own Citius Pharmaceuticals?

Yes, BlackRock owns 1.14% of Citius Pharmaceuticals, totaling 1.81M shares as of Jun 2024. This represents 0% of BlackRock's total assets, with a market value of 1.05M$. In the last quarter, BlackRock decreased its holdings by -6.921M shares, a -79.31% change.

Who is Citius Pharmaceuticals’s biggest shareholder by percentage of total assets invested?

Chelsea counsel is Citius Pharmaceuticals’s biggest shareholder by percentage of total assets invested, with 0.00% of its assets in 4.63K Citius Pharmaceuticals shares, valued at 7.36K$.

Who is the top mutual fund holder of Citius Pharmaceuticals shares?

Vanguard US Total Market Shares ETF is the top mutual fund holder of Citius Pharmaceuticals shares, with 2.60% of its total shares outstanding invested in 4.14M Citius Pharmaceuticals shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools